Takahiro Nagashima Selected Research

Hypoxia (Hypoxemia)

8/2009

Inhibition of hypoxia-inducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takahiro Nagashima Research Topics

Disease

4	Multiple Myeloma 01/2020 - 01/2004
3	Neoplasms (Cancer) 01/2022 - 08/2009
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2018 - 09/2003
3	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2006 - 09/2003
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2022 - 01/2022
2	Chest Pain (Chest Pains) 01/2018 - 04/2010
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2008 - 06/2007
2	Virus Diseases (Viral Diseases) 01/2004 - 09/2003
1	Residual Neoplasm 02/2022
1	Listeria Meningitis 01/2020
1	Gastrointestinal Hemorrhage (Hematochezia) 01/2020
1	Infections 01/2020
1	Pancytopenia 01/2020
1	Essential Thrombocythemia 01/2018
1	Takotsubo Cardiomyopathy 01/2018
1	Cardiomyopathies (Cardiomyopathy) 04/2010
1	Fever (Fevers) 04/2010
1	Hypoxia (Hypoxemia) 08/2009
1	Leukemia 01/2008
1	Sepsis (Septicemia) 01/2008
1	Leukocytosis (Pleocytosis) 08/2006
1	Infertility (Sterility) 03/2005
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2005
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2004
1	Hematologic Neoplasms (Hematological Malignancy) 01/2004
1	Paraproteinemias (Monoclonal Gammopathy) 01/2004
1	Fanconi Anemia (Fanconi's Anemia) 03/2002

Drug/Important Bio-Agent (IBA)

2	Dasatinib (BMS 354825)FDA Link 07/2018 - 02/2016
2	Methotrexate (Mexate)FDA LinkGeneric 06/2007 - 09/2003
2	Tacrolimus (Prograf)FDA LinkGeneric 08/2006 - 09/2003
1	Core Binding Factors (Core-Binding Factor)IBA 02/2022
1	C-Reactive ProteinIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	AlbuminsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	Bence Jones ProteinIBA 01/2020
1	daratumumabIBA 01/2020
1	Pharmaceutical PreparationsIBA 07/2018
1	anagrelide (Agrylin)FDA LinkGeneric 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2010
1	Antifungal AgentsIBA 04/2010
1	Nitric AcidIBA 04/2010
1	Melphalan (Alkeran)FDA LinkGeneric 08/2009
1	Apoptosis Regulatory ProteinsIBA 08/2009
1	EnzymesIBA 08/2009
1	Transcription Factors (Transcription Factor)IBA 08/2009
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2008
1	sobuzoxaneIBA 06/2007
1	Vincristine (Oncovin)FDA LinkGeneric 06/2007
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2007
1	Etoposide (VP 16)FDA LinkGeneric 06/2007
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2006
1	Calcineurin InhibitorsIBA 08/2006
1	ParaproteinsIBA 01/2004
1	SteroidsIBA 09/2003
1	HLA-DR Antigens (HLA-DR)IBA 09/2003
1	Phosphotransferases (Kinase)IBA 03/2002
1	Fanconi Anemia Complementation Group A ProteinIBA 03/2002
1	Proteins (Proteins, Gene)FDA Link 03/2002

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 04/2010 - 03/2005
3	Therapeutics 01/2020 - 01/2008
2	Hematopoietic Stem Cell Transplantation 02/2022 - 01/2004
2	Stem Cell Transplantation 08/2006 - 03/2005
2	Transplantation 08/2006 - 01/2004
1	Salvage Therapy 04/2010